MedTrace Logo

VEGA Prospective Kiel

NCT02802085 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 84

Last updated 2019-01-23

No results posted yet for this study

Summary

Voluntary Post-Marketing Clinical Follow-up (PMCF) as part of the post marketing surveillance plan for the product under investigation.

For this PMCF only CE-marked medical devices have been used and will be used within their intended purpose and no additional invasive or other stressful examinations have been or are to be carried out (acc. to MPG §23b).

Conditions

Interventions

DEVICE

VEGA Knee

TKA

Sponsors & Collaborators

  • Frictionless GmbH

    collaborator UNKNOWN

  • Aesculap AG

    lead INDUSTRY

Principal Investigators

  • Ludger Gerdesmeyer, Professor · orthopedics

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2018-02-28
Completion
2018-02-28

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02802085 on ClinicalTrials.gov